Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Full description

Bibliographic Details
Main Authors: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Online Access:https://journal.transpl.ru/vtio/article/view/1194

Internet

https://journal.transpl.ru/vtio/article/view/1194

Similar Items